These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1453550

  • 21. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K, Kino K, Horisawa S, Nishimura T, Muraoka M, Noguchi T, Ohashi N.
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [Abstract] [Full Text] [Related]

  • 22. Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits.
    Xu G, Salen G, Shefer S, Ness GC, Nguyen LB, Parker TS, Chen TS, Zhao Z, Donnelly TM, Tint GS.
    J Clin Invest; 1995 Apr; 95(4):1497-504. PubMed ID: 7706454
    [Abstract] [Full Text] [Related]

  • 23. [Research and development of pravastatin].
    Kishida Y, Naito A, Iwado S, Terahara A, Tsujita Y.
    Yakugaku Zasshi; 1991 Sep; 111(9):469-87. PubMed ID: 1762049
    [Abstract] [Full Text] [Related]

  • 24. Clearance of chylomicron-like lipid emulsions is increased in normal rabbits but not in heterozygous Watanabe heritable hyperlipidaemic rabbits following treatment with cholestyramine or pravastatin.
    Mamo JC, Bowler A, Redgrave TG, Elsegood CL.
    Clin Exp Pharmacol Physiol; 1994 Sep; 21(9):687-94. PubMed ID: 7820948
    [Abstract] [Full Text] [Related]

  • 25. Effects of long-term administration of HMG-CoA reductase inhibitors on cholesterol synthesis in lens.
    Kalinowski SS, Tanaka RD, Mosley ST.
    Exp Eye Res; 1991 Aug; 53(2):179-86. PubMed ID: 1915674
    [Abstract] [Full Text] [Related]

  • 26. [Effect of pravastatin on hepatic cholesterol metabolism].
    Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B.
    Fortschr Med; 1991 Mar 20; 109(8):189-94. PubMed ID: 1905265
    [Abstract] [Full Text] [Related]

  • 27. Pravastatin sodium, an inhibitor of HMG-CoA reductase, decreases HDL cholesterol by transfer of cholesteryl ester from HDL to VLDL in Japanese white rabbits.
    Miyazaki A, Koieyama T, Shimada Y, Kikuchi T, Ito K, Kasanuki N, Koga T.
    J Atheroscler Thromb; 2004 Mar 20; 11(1):22-8. PubMed ID: 15067195
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethyl glutaryl coenzyme A reductase in rat liver.
    Carrella M, Fong LG, Loguercio C, Del Piano C.
    Metabolism; 1999 May 20; 48(5):618-26. PubMed ID: 10337863
    [Abstract] [Full Text] [Related]

  • 29. Reduced cholesterol esterification in CaCo-2 cells by indirect action of pravastatin.
    Reimann FM, Winkelmann F, Fellermann K, Stange EF.
    Atherosclerosis; 1996 Aug 23; 125(1):63-70. PubMed ID: 8831928
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of single administration of pravastatin sodium on hepatic cholesterol metabolism in rats.
    Fujioka T, Tsujita Y.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):223-8. PubMed ID: 9128842
    [Abstract] [Full Text] [Related]

  • 33. Effects of MK-733 (simvastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on intestinal acylcoenzyme A:cholesterol acyltransferase activity in rabbits.
    Ishida F, Sato A, Iizuka Y, Kitani K, Sawasaki Y, Kamei T.
    Biochim Biophys Acta; 1989 Jul 17; 1004(1):117-23. PubMed ID: 2742865
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
    Jiang C, Wang Q, Wei Y, Yao N, Wu Z, Ma Y, Lin Z, Zhao M, Che C, Yao X, Zhang J, Yin Z.
    J Ethnopharmacol; 2015 Dec 24; 176():17-26. PubMed ID: 26477373
    [Abstract] [Full Text] [Related]

  • 37. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND, Liang K.
    Am J Nephrol; 2004 Dec 24; 24(6):606-13. PubMed ID: 15583480
    [Abstract] [Full Text] [Related]

  • 38. Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.
    Purdy BH, Field FJ.
    J Clin Invest; 1984 Aug 24; 74(2):351-7. PubMed ID: 6746898
    [Abstract] [Full Text] [Related]

  • 39. [Inhibitory action of natural compounds of microbial origin on cholesterol metabolism].
    Fujioka T.
    Nihon Yakurigaku Zasshi; 1997 Oct 24; 110 Suppl 1():75P-80P. PubMed ID: 9503410
    [Abstract] [Full Text] [Related]

  • 40. Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies.
    Keidar S, Aviram M, Maor I, Oiknine J, Brook JG.
    Br J Clin Pharmacol; 1994 Dec 24; 38(6):513-9. PubMed ID: 7888289
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.